Evidence map›Paper›PMID 32456036›Full record

ReviewPathogens (Basel, Switzerland)2020

A Review:

Pei-Shi Yen, Anna-Bella Failloux

Open access · goldAbstract readReview
In one paragraph

Review in Pathogens (Basel, Switzerland), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 51 papers.

0numbers the graph read from it
0cells of the map it votes in
51citing papers in PubMed
9.0field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

51 citing papers in PubMed, 89 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Detection of novelFrontiers in microbiology · 2026
    Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. ExploitingPathogens (Basel, Switzerland) · 2025
    Review
  12. Life table variations inFrontiers in insect science · 2025
    Article
  13. UnveilingFrontiers in cellular and infection microbiology · 2025
    Article
  14. West Nile virus unmasked: from gene variability to future challenges.Frontiers in cellular and infection microbiology · 2025
    Review
  15. Review
  16. Article
  17. Mosquito Gut Microbiota: A Review.Pathogens (Basel, Switzerland) · 2024
    Review
  18. Article
  19. Wolbachia: Advancing into a Second Century.Methods in molecular biology (Clifton, N.J.) · 2024
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Pei-Shi YenUnit Arboviruses and Insect Vectors, Department of Virology, Institut Pasteur, F-75724 Paris, France.
Anna-Bella FaillouxUnit Arboviruses and Insect Vectors, Department of Virology, Institut Pasteur, F-75724 Paris, France.ORCID 0000-0001-6890-0820
Institut Pasteur · FR

Funding

French Government's Investissement d'Avenir program, Laboratoire d'Excellence "Integrative Biology of Emerging Infectious Diseases, IBEID" n_ANR-10-LABX-62-IBEIDNational Health Research Institutes NHRI-PP-108-0324-01-17-07
6 · The paper itself

Abstract

The growing expansion of mosquito vectors has made mosquito-borne arboviral diseases a global threat to public health, and the lack of licensed vaccines and treatments highlight the urgent need for efficient mosquito vector control. Compared to genetically modified control strategies, the intracellular bacterium

Indexed as

arbovirusenvironmental factorsmosquito controlreplacement strategyviral adaptationWolbachia

Identifiers

PMID32456036
PMCPMC7281599
OpenAlexW3028571801

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.